title: The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.
authors.affiliation: Department of Neurology, National Neuroscience Institute, Singapore; Montefiore Headache Center, Montefiore Medical Center, Bronx, NY, USA.
authors.forename: Yasmin Idu
authors.initials: YI
authors.lastname: Jion
authors.forename: Amanda
authors.initials: A
authors.lastname: Raff
authors.forename: Brian M
authors.initials: BM
authors.lastname: Grosberg
authors.forename: Randolph W
authors.initials: RW
authors.lastname: Evans
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D007669:Kidney Calculi / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy; D011559:Pseudotumor Cerebri / Q000150:complications / Q000188:drug therapy; D000077236:Topiramate; D000078305:Zonisamide
chemical_list: D000927:Anticonvulsants; D007555:Isoxazoles; D000077236:Topiramate; D005632:Fructose; D000078305:Zonisamide
keywords: idiopathic intracranial hypertension; kidney stone; migraine; topiramate; zonisamide